UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018159
Receipt number R000021011
Scientific Title The prospective observational study of incidence rate of hepatic composite event in NAFLD patients
Date of disclosure of the study information 2015/07/02
Last modified on 2019/05/08 09:07:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The prospective observational study of incidence rate of hepatic composite event in NAFLD patients

Acronym

The prospective observational study of incidence rate of hepatic composite event in NAFLD patients

Scientific Title

The prospective observational study of incidence rate of hepatic composite event in NAFLD patients

Scientific Title:Acronym

The prospective observational study of incidence rate of hepatic composite event in NAFLD patients

Region

Japan


Condition

Condition

Nonalcoholic fatty liver disease (NAFLD)

Classification by specialty

Medicine in general Gastroenterology Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the incidence of composite hepatic events between fibrotic NASH and the other NAFLD patients.

Basic objectives2

Others

Basic objectives -Others

Prognosis investigation

Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

1) Incidence of composite hepatic events
[Composite hepatic event]
-Compensated cirrhosis
-Hepatocellular carcinoma
-Progress from compensated cirrhosis to decompensated cirrhosis
-Liver cirrhosis complication (Hepatic encephalopathy , Gastroesophageal varices , Rupture of gastroesophageal varices , Ascites , Jaundice)
-Liver transplant

2) Incidence of cerebrovascular and cardiovascular events
[Cerebrovascular and cardiovascular events]
-Stroke
-Ischemic heart disease (Myocardial infarction , Angina pectoris)

3) Incidence of extrahepatic cancer excepting the liver

4) Death rate

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients who participate in previous study (Diagnostic accuracy of novel scoring systems using serum biomarkers for nonalcoholic steatohepatitis (NASH) : Protocol number 14002-DSP1747)

2) Patients who voluntarily agree to participate in the study by providing written informed consent. However, this may not be applicable if the requirements mentioned in Part 12 1 (2) A (b) of "Ethical Guidelines for Medical and Health Research Involving Human Subjects" are satisfied.

Key exclusion criteria

In the opinion of the investigator, patient are unsuitable as a study subject

Target sample size

400


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name (1)Takeshi Okanoue (2)Hiromitsu Kumada

Organization

(1)Saiseikai Suita Hospital
(2)Toranomon Hospital Kajigaya

Division name

(1)Honorary Director (2)Director General

Zip code


Address

(1)1-2.Kawazono-cho Suita-shi Osaka-fu JAPAN (2)1-3-1.Kajigaya.Takatsu-ku Kawasaki-shi Kanagawa-ken JAPAN

TEL

(1)06-6382-1521(2)044-877-5111

Email

okanoue@suita.saiseikai.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Fumiyuki Iida

Organization

Sogo Rinsho Medefi Co.,Ltd.

Division name

Business promotion department

Zip code


Address

9F KDX Shinjuku Building 3-2-7 Nishi Shinjuku Shinjuku-ku Tokyo-to JAPAN

TEL

03-6901-6079

Homepage URL


Email

nafld@sogo-medefi.jp


Sponsor or person

Institute

Saiseikai Suita Hospital

Institute

Department

Personal name



Funding Source

Organization

Sumitomo Dainippon Pharma Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪府済生会吹田病院(大阪府)


Other administrative information

Date of disclosure of the study information

2015 Year 07 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 04 Month 23 Day

Date of IRB

2015 Year 04 Month 23 Day

Anticipated trial start date

2015 Year 07 Month 21 Day

Last follow-up date

2018 Year 05 Month 23 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Incidence of hepatic compsite event in nonalcoholic fatty liver disease patients


Management information

Registered date

2015 Year 07 Month 02 Day

Last modified on

2019 Year 05 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021011


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name